Cinclus Pharma Holding AB
CINPHA | ST
Overview
Corporate Details
- ISIN(s):
- SE0020388577
- LEI:
- 549300TJBPSNZ3DO6B42
- Country:
- Sweden
- Address:
- Kungsbron 1, Plan 3, trappa G, 111 22 Stockholm
- Website:
- https://cincluspharma.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Cinclus Pharma Holding AB is a Swedish biopharma company developing treatments for gastrointestinal diseases, with a focus on acid-related disorders.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 20:12 |
Post-Annual General Meeting Information
Beslut vid årsstämma i Cinclus Pharma Holding AB (publ) den 22 maj 2025
|
Swedish | 79.8 KB | |
| 2025-05-22 20:12 |
Post-Annual General Meeting Information
Resolutions at the Annual General Meeting in Cinclus Pharma Holding AB (publ) o…
|
English | 81.2 KB | |
| 2025-05-22 07:30 |
M&A Activity
Cinclus Pharma ingår partnerskap med Zentiva för att kommersialisera linaprazan…
|
Swedish | 93.4 KB | |
| 2025-05-22 07:30 |
M&A Activity
Cinclus Pharma Partners with Zentiva to Commercialize Linaprazan Glurate in Eur…
|
English | 92.2 KB | |
| 2025-05-20 08:00 |
Quarterly Report
|
Swedish | 2.5 MB | |
| 2025-05-20 08:00 |
Quarterly Report
|
English | 2.6 MB | |
| 2025-04-30 16:00 |
Annual Report (ESEF)
|
Swedish | 29.7 MB | |
| 2025-04-30 16:00 |
Annual Report (ESEF)
|
English | 29.7 MB | |
| 2025-02-20 08:00 |
Annual Report
|
Swedish | 2.3 MB | |
| 2025-02-20 08:00 |
Annual Report
|
English | 2.3 MB | |
| 2025-01-03 17:00 |
Major Shareholding Notification
|
Swedish | 8.1 KB | |
| 2024-12-30 14:00 |
Share Issue/Capital Change
Antal aktier och röster i Cinclus Pharma
|
Swedish | 84.1 KB | |
| 2024-12-30 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Cinclus Pharma
|
English | 83.0 KB | |
| 2024-11-28 19:30 |
Share Issue/Capital Change
Emission och återköp av C-aktier
|
Swedish | 76.8 KB | |
| 2024-11-28 19:30 |
Share Issue/Capital Change
Issue and repurchase of class C shares
|
English | 76.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG | |
|
Nattaro Labs AB | Sweden | NATTA | |
|
Neovacs | France | ALNEV | |
|
Newron Pharmaceuticals S.p.A. | Italy | NWRN | |
|
NextCell Pharma AB | Sweden | NXTCL | |
|
NextFerm Technologies Ltd. | Israel | NXFR | |
|
NFL Biosciences | France | ALNFL | |
|
Nortem BioGroup | Spain | MLBIO |